• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[维拉帕米对多发性骨髓瘤患者血小板功能的影响]

[The influence of verapamil on platelet function in patients with multiple myeloma].

作者信息

Sokołowska B, Dmoszyńska A, Walter-Croneck A, Wojtaszko M

机构信息

Kliniki Hematologii Akademii Medycznej w Lublinie.

出版信息

Pol Merkur Lekarski. 1997 Feb;2(8):109-10.

PMID:9538652
Abstract

Influence of verapamil on platelet function was evaluated in 7 female and 8 male patients with myeloma. The inhibitory effect on platelet aggregation and other parameters was documented in clinical observation.

摘要

在7名女性和8名男性骨髓瘤患者中评估了维拉帕米对血小板功能的影响。临床观察记录了其对血小板聚集及其他参数的抑制作用。

相似文献

1
[The influence of verapamil on platelet function in patients with multiple myeloma].[维拉帕米对多发性骨髓瘤患者血小板功能的影响]
Pol Merkur Lekarski. 1997 Feb;2(8):109-10.
2
[Chemotherapy of multiple myeloma].[多发性骨髓瘤的化疗]
Sov Med. 1991(3):43-6.
3
[Pneumonia caused by Salmonella in a patient with myeloma].[一名骨髓瘤患者的沙门氏菌肺炎]
Sangre (Barc). 1995 Jun;40(3):234-5.
4
[Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].[采用美法仑、泼尼松、环磷酰胺、长春新碱和卡氮芥治疗II期和III期多发性骨髓瘤（M-2方案）]
Rev Clin Esp. 1985 May;176(8):392-5.
5
[Treatment of multiple myeloma in stages I and II. Comparative study of an M-2 protocol and melphalan-prednisone].[Ⅰ期和Ⅱ期多发性骨髓瘤的治疗。M-2方案与美法仑-泼尼松的对比研究]
Sangre (Barc). 1984;29(6):993-9.
6
Refractory multiple myeloma treated with homoharringtonine: report of two cases.高三尖杉酯碱治疗难治性多发性骨髓瘤：两例报告
Ann Hematol. 2007 Dec;86(12):919-21. doi: 10.1007/s00277-007-0331-5. Epub 2007 Jul 20.
7
Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness.
Cancer Treat Rep. 1984 Dec;68(12):1439-46.
8
Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.多发性骨髓瘤的细胞动力学与治疗：M83方案的更新
Bone Marrow Transplant. 1989 Jan;4 Suppl 1:168-9.
9
Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
Arch Immunol Ther Exp (Warsz). 1981;29(2):145-53.
10
[Preleukemia myelodysplastic syndrome after chemotherapy for multiple myeloma: "a new case"].多发性骨髓瘤化疗后白血病前期骨髓增生异常综合征：“1例新病例”
Sangre (Barc). 1991 Oct;36(5):434-5.